PD Evaluation of New Drugs

Based on experience cumulated during the years and continuous improvement and innovation, we have established a comprehensive animal model library which can provide various effective animal models according to customer’s needs so that to form a reliable evaluation basis for your product’s PD research. The experimental animals that we can provide include dogs, rats and mice, rabbits, guinea pigs, miniature pigs, monkeys, etc., to support the PD evaluation of anti-infective and antitumor drugs, multidisciplines (including ophthalmology and pediatrics) and various diseases, such as digestive system diseases, autoimmune diseases, diabetes and complications, cardiovascular and cerebrovascular diseases, and endocrine diseases.

Service Contents

◆PD studies of ophthalmic drugs (glaucoma, cataract, ocular surface diseases, CNV, AMD, ocular tumors, etc.)

◆PD studies of pediatric drugs (anti-infective drug, antipyretic, anti-inflammatory immune, respiratory, gastrointestinal and other common pediatric diseases)

◆Digestive system diseases (peptic ulcer, reflux esophagitis, hepatitis, liver fibrosis, etc.)

◆Anti-infective drugs

◆Neurological behavior (learning, memory disorders, behavior, motor functions, etc.)

◆Anti-tumor (subcutaneous transplantation, orthotopic transplantation, peritoneal inoculation, etc.)

◆Autoimmune diseases (systemic lupus erythematosus, leukocytopia model, etc.)

◆Anti-glucocorticoid side effects (hormone metabolism disorder model, withdrawal reaction model, neuroendocrine inhibition model)

◆Diabetes and complications (multiple spontaneous models, experimental diabetes, DIO)

◆Cardiovascular and cerebrovascular diseases (hypertension, heart disease, cerebral ischemia, peripheral blood flow disorders, etc.)

◆Endocrine disorders (hyperlipidemia, osteoporosis, hyperuricemia, etc.)

◆Anti-inflammatory immunity (inflammations, pain models, cellular immunity, humoral immunity, etc.)